VBWG
Monograph

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

• New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy, is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine. Co-editors are Carl J. Pepine, MD, University of Florida College of Medicine, and James O'Keefe, MD, FACC, University of Missouri-Kansas City Medical School.

Advances in the identification and validation of risk factors for cardiovascular disease (CVD) have been substantial. In this monograph, recently published results from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and related studies are discussed in the context of hypertension and dyslipidemia. These trials assess the efficacy of agents targeting multiple mechanisms of CVD in patients with defined risk factors.




CME_monograph.pdf (1.1MB)CME_monograph.pdf (1.1MB)
The contents of this monograph express the views of the individual contributors and do not necessarily reflect the views or recommendations of the University of Florida College of Medicine, University of Missouri-Kansas City Medical School, or the publisher. The reader is advised to consult the full prescribing information for all medications prior to use.

Supported by an educational grant from Pfizer Inc.

© 2006 MEDCONSM All rights reserved.

biologycontinuingEducationFloridamonographTMvascularVol

Related at vwbg.org

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 2

High-dose statins and early benefit in ACS: Role of inflammation

This monograph, High-dose statins and early benefit in ACS: Role of inflammation , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More related